ENvue Medical, Inc.
For the period ended Dec 31, 2024. Filed Mar 31, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Mar 31, 2025
FEED$1.03-69.3%Stored close · as of Sep 15, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
ITEM 15. : EXHIBITS, FINANCIAL STATEMENT SCHEDULES
ITEM 15. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES
The following documents are filed as part of this Annual Report on Form 10-K:
| (1) | Financial Statements: |
| Report of Independent Registered Public Accounting Firm (PCAOB ID: 549) | F-1 |
|---|---|
| Consolidated Balance Sheets as of December 31, 2024, and 2023 | F-2 |
| Consolidated Statements of Operations and Comprehensive Loss for the years ended December 31, 2024, and 2023 | F-3 |
| Consolidated Statements of Changes in Stockholders’ Equity for the years ended December 31, 2024, and 2023 | F-4 |
| Consolidated Statements of Cash Flows for the years ended December 31, 2024, and 2023 | F-5 |
| Notes to Consolidated Financial Statements | F-6 |
| (2) | Financial Statement Schedules: |
None.
| (3) | Exhibits: |
See “Index to Exhibits” for a description of our exhibits.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.